Item Type | Name |
Concept
|
Psychiatric Status Rating Scales
|
Academic Article
|
Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study.
|
Academic Article
|
Hypericum extract in patients with MDD and reversed vegetative signs: re-analysis from data of a double-blind, randomized trial of hypericum extract, fluoxetine, and placebo.
|
Academic Article
|
Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial.
|
Academic Article
|
A Double-blind, randomized trial of St John's wort, fluoxetine, and placebo in major depressive disorder.
|
Academic Article
|
High-dose sertraline strategy for nonresponders to acute treatment for obsessive-compulsive disorder: a multicenter double-blind trial.
|
Academic Article
|
Efficacy and safety of agomelatine in the treatment of major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled trial.
|
Academic Article
|
L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials.
|
Academic Article
|
Residual symptoms in major depressive disorder: prevalence, effects, and management.
|
Academic Article
|
Effect of cognitive therapy with antidepressant medications vs antidepressants alone on the rate of recovery in major depressive disorder: a randomized clinical trial.
|
Academic Article
|
A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive Disorder.
|
Academic Article
|
Antidepressant combination and potentiation.
|
Academic Article
|
Innovative somatic treatments for depression.
|
Academic Article
|
CNS stimulant potentiation of monoamine oxidase inhibitors in treatment-refractory depression.
|
Academic Article
|
The efficacy of fluoxetine combined with a heterocyclic antidepressant in treatment-resistant depression: a retrospective analysis.
|
Academic Article
|
The effect of nefazodone on comorbid anxiety symptoms associated with depression: experience in family practice and psychiatric outpatient settings.
|
Academic Article
|
Importance of establishing the diagnosis of persistent anxiety.
|
Academic Article
|
Multicenter double-blind comparison of sertraline and desipramine for concurrent obsessive-compulsive and major depressive disorders.
|
Academic Article
|
Construct validity of life chart functioning scales for use in naturalistic studies of bipolar disorder.
|
Academic Article
|
Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire.
|
Academic Article
|
Intramuscular ziprasidone, 2 mg versus 10 mg, in the short-term management of agitated psychotic patients.
|
Academic Article
|
Efficacy and safety of mirtazapine in major depressive disorder patients after SSRI treatment failure: an open-label trial.
|
Academic Article
|
Symptomatic and syndromal anxiety in chronic forms of major depression: effect of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination.
|
Academic Article
|
Divalproex sodium versus olanzapine in the treatment of acute mania in bipolar disorder: health-related quality of life and medical cost outcomes.
|
Academic Article
|
Prevention of Recurrence After Recovery From a Major Depressive Episode With Antidepressant Medication Alone or in Combination With Cognitive Behavioral Therapy: Phase 2 of a 2-Phase Randomized Clinical Trial.
|
Academic Article
|
Double-blind, placebo-controlled, proof-of-concept trial of a kappa-selective opioid receptor antagonist augmentation in treatment-resistant depression.
|